Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Salvianolic acid, a major water-soluble compound extracted from the root of Salvia miltiorrhiza (Danshen), has been investigated for its gastroprotective effects, including potential benefit in ulcer management. Several preclinical studies in animal models have shown that salvianolic acid can reduce gastric mucosal injury induced by factors like ethanol or NSAIDs. These effects are attributed to its antioxidant activity, ability to improve microcirculation, and suppression of inflammatory mediators. For example, research published in Phytomedicine and Journal of Ethnopharmacology (e.g., Li et al., 2014; Zhang et al., 2015) demonstrated that salvianolic acid B attenuated oxidative stress and inflammation in gastric tissue, which are central in ulcer pathogenesis.

However, clinical evidence in humans is currently lacking, and no large-scale randomized controlled trials have evaluated salvianolic acid specifically for ulcer treatment or prevention in people. Most human data for Danshen relate to its cardiovascular uses. Thus, while there is a scientific basis from laboratory research and traditional use of Danshen for digestive issues, current support for salvianolic acid as a treatment for ulcers should be considered preliminary and unproven in clinical practice. Further research is needed to confirm efficacy and safety in humans.

More about Salvianolic acid
More about Ulcers

Other ingredients used for Ulcers

Other health conditions supported by Salvianolic acid

Products containing Salvianolic acid